FRANCISCO J. DE LA
SERNA TORROBA
Profesor asociado de Ciencias de la Salud
JOAQUÍN
MARTÍNEZ LÓPEZ
Catedrático de universidad
Publicaciones en las que colabora con JOAQUÍN MARTÍNEZ LÓPEZ (9)
2023
-
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)
Leukemia
-
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Leukemia, Vol. 37, Núm. 2, pp. 339-347
2018
-
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia
Oncotarget, Vol. 9, Núm. 40, pp. 26019-26031
2011
-
Relationship between deoxycytidine kinase (DCK) genotypic variants and fludarabine toxicity in patients with follicular lymphoma
Leukemia Research, Vol. 35, Núm. 4, pp. 431-437
2009
-
Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide
Leukemia and Lymphoma, Vol. 50, Núm. 8, pp. 1283-1289
2003
-
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial
British Journal of Haematology, Vol. 120, Núm. 2, pp. 296-303
2002
-
Myeloablative treatments for multiple myeloma: Update of a comparative study of different regimens used in patients from the Spanish Registry for transplantation in multiple myeloma
Leukemia and Lymphoma, Vol. 43, Núm. 1, pp. 67-74
2000
-
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: A comparative study of efficacy and toxicity from the Spanish Registry for transplantation in multiple myeloma
British Journal of Haematology, Vol. 109, Núm. 1, pp. 138-147
-
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients
British Journal of Haematology, Vol. 109, Núm. 2, pp. 438-446